146 related articles for article (PubMed ID: 33439703)
1. The Need for Novel Approaches in Assessing the Value of COVID-19 Vaccines.
Angelis A; Baltussen R; Tervonen T
Am J Public Health; 2021 Feb; 111(2):205-208. PubMed ID: 33439703
[No Abstract] [Full Text] [Related]
2. Assessing the Safety of COVID-19 Vaccines: A Primer.
Petousis-Harris H
Drug Saf; 2020 Dec; 43(12):1205-1210. PubMed ID: 32997318
[TBL] [Abstract][Full Text] [Related]
3. Can expedited FDA drug approval without expedited follow-up be trusted?
Carpenter D
JAMA Intern Med; 2014 Jan; 174(1):95-7. PubMed ID: 24165977
[No Abstract] [Full Text] [Related]
4. Global covid-19 vaccine rollout and safety surveillance-how to keep pace.
Lo Re V; Klungel OH; Chan KA; Panozzo CA; Zhou W; Winterstein AG
BMJ; 2021 Jun; 373():n1416. PubMed ID: 34144957
[No Abstract] [Full Text] [Related]
5. Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
Lee GM; Romero JR; Bell BP
JAMA; 2020 Nov; 324(19):1937-1938. PubMed ID: 33064152
[No Abstract] [Full Text] [Related]
6. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.
Pai SM; Othman AA; Rusch L; Masters JC; Greene D; Rogge M; Gries JM; Clementi W; Kumar P; Younis I; Salem AH; Gaynes BI; Pastino G; Derendorf H;
J Clin Pharmacol; 2021 Mar; 61(3):277-279. PubMed ID: 33274473
[No Abstract] [Full Text] [Related]
7. Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.
Skydel JJ; Luxkaranayagam AT; Dhruva SS; Ross JS; Wallach JD
JAMA Netw Open; 2019 May; 2(5):e193410. PubMed ID: 31074812
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018.
Wallach JD; Ramachandran R; Bruckner T; Ross JS
JAMA Netw Open; 2021 Nov; 4(11):e2133601. PubMed ID: 34751764
[TBL] [Abstract][Full Text] [Related]
9. Tackling sheepishness about a COVID-19 vaccine for the sake of herd immunity.
Gildea F
Perspect Public Health; 2020 Nov; 140(6):301-302. PubMed ID: 33222626
[No Abstract] [Full Text] [Related]
10. Review of clinical trial settings of drugs commonly used in primary care and approved between 2005 and 2012.
Crossley JR; Tan TP; Smith KH; Ross JS; Merenstein DJ
J Gen Intern Med; 2018 Sep; 33(9):1431-1432. PubMed ID: 29777429
[No Abstract] [Full Text] [Related]
11. Transforming vaccine development.
Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
[TBL] [Abstract][Full Text] [Related]
12. Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent.
Mazraani M; Barbari A
Exp Clin Transplant; 2021 Aug; 19(8):753-762. PubMed ID: 34407747
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccines and treatments: When speed is necessary and not enough.
Grasela TH; Price DA; Wagner JA
Clin Transl Sci; 2021 Jul; 14(4):1201-1205. PubMed ID: 33834614
[No Abstract] [Full Text] [Related]
14. Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015.
MacGregor A; Zhang AD; Wallach JD; Ross JS; Herder M
JAMA Netw Open; 2020 Jul; 3(7):e209498. PubMed ID: 32706379
[TBL] [Abstract][Full Text] [Related]
15. The statin wars.
McKillop T
Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
[No Abstract] [Full Text] [Related]
16. Talk to Patients About: Vaccine Testing.
Price S
Tex Med; 2020 Nov; 116(11):23. PubMed ID: 33641134
[TBL] [Abstract][Full Text] [Related]
17. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
18. An Informative Discussion for School Nurses on COVID-19 mRNA Vaccine.
Gordon J; Reynolds M; Barnby E
NASN Sch Nurse; 2021 May; 36(3):132-136. PubMed ID: 33825584
[TBL] [Abstract][Full Text] [Related]
19. How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream.
Witek TJ
Pharmaceut Med; 2021 Sep; 35(5):287-295. PubMed ID: 34580837
[TBL] [Abstract][Full Text] [Related]
20. ASHP principles for COVID-19 vaccine distribution, allocation, and mass immunization.
Am J Health Syst Pharm; 2020 Dec; 77(24):2112-2113. PubMed ID: 32871003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
